Fig. 1From: Assessment of three fasting plasma glucose targets for insulin glargine-based therapy in people with type 2 diabetes mellitus in China: study protocol for a randomized controlled trialSchematic flow diagram of the study design. FPG fasting plasma glucose, OAD oral antihyperglycemic drugBack to article page